Skip to content

13F-HR filed by Ghost Tree Capital, LLC

Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2014-06-30, filed 2014-08-14, with 54 holding rows worth $141,782,000.

Accession
0001164691-14-000181
Filed
2014-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2014

A holdings report, 54 entries on the cover page, a total value of $141,782,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $141,782,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPDR S&P 500 ETF TR78462F953PUT75,000$14,679,000thousands by filing dateput
MYLAN INC628530907COM150,000$7,734,000thousands by filing datecall
ACTAVIS PLCG0083B108SHS30,000$6,692,000thousands by filing date
MEDIVATION INC58501N101COM80,000$6,166,000thousands by filing date
THE COOPER COMPANIES216648402COM NEW40,000$5,421,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR100,000$5,242,000thousands by filing date
Boston Scientific Corporation101137107COM400,000$5,108,000thousands by filing date
MEDTRONIC INC585055106COM75,000$4,782,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock75,000$4,738,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK100,000$4,537,000thousands by filing date
ATRICURE INC04963C209COM225,000$4,136,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock200,000$3,996,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J906COM300,000$3,621,000thousands by filing datecall
SPECTRANETICS CORP84760C107COM142,600$3,263,000thousands by filing date
BRUKER CORP116794108COM130,000$3,155,000thousands by filing date
SYNAGEVA BIOPHARMA CORP87159A103COM30,000$3,144,000thousands by filing date
TORNIER NVN87237108COMMON STOCK-FO120,000$2,806,000thousands by filing date
COVIDIEN PLCG2554F113SHS30,000$2,705,000thousands by filing date
ANACOR PHARMACEUTICALS INC032420101COM150,000$2,660,000thousands by filing date
HCA Healthcare Inc40412C101COM45,000$2,537,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM10,000$2,366,000thousands by filing date
ATRIUM THERAPEUTICS INCN71546100COM175,000$2,209,000thousands by filing date
ACCURAY INC DEL004397105COM250,000$2,200,000thousands by filing date
ENANTA PHARMACEUTICALS INC29251M106COM50,000$2,154,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS20,000$2,146,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock7,500$2,119,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM100,000$2,072,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM600,000$2,004,000thousands by filing date
SMITH & NEPHEW PLC SPDN ADR NEW83175M205ADR20,000$1,786,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock20,000$1,717,000thousands by filing date
DEPOMED INC249908104COM120,000$1,668,000thousands by filing date
DEPOMED INC CMN STOCK249908954Cmn120,000$1,668,000thousands by filing dateput
NPS PHARMACEUTICALS INC CMN STOCK62936P903Cmn50,000$1,653,000thousands by filing datecall
OREXIGEN THERAPEUTICS INC686164104COMMON STOCK250,000$1,545,000thousands by filing date
RECEPTOS, INC.756207106COMMON STOCK35,000$1,491,000thousands by filing date
NPS PHARMACEUTICALS INC62936P103COM40,000$1,322,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q901Cmn150,000$1,136,000thousands by filing datecall
FLAMEL TECHNOLOGIES-SP ADR338488109SPON75,000$1,125,000thousands by filing date
CATALYST PHARMACEUTICALS INC14888U101COM437,296$1,106,000thousands by filing date
THERAPEUTICSMD INC88338N107COM250,000$1,105,000thousands by filing date
INOVIO PHARMACEUTICALS INC45773H951COM NEW100,000$1,081,000thousands by filing dateput
Cynosure, Inc.232577205COM50,000$1,063,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM70,000$1,047,000thousands by filing date
AIR METHODS CORP009128307COM PAR $.0620,000$1,033,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM75,000$956,000thousands by filing date
UNILIFE CORP NEW90478E103COM300,000$888,000thousands by filing date
HERON THERAPEUTICS INC427746102COM70,000$862,000thousands by filing date
OCERA THERAPEUTICS INC COM67552A108COM100,000$764,000thousands by filing date
REVANCE THERAPEUTICS INC761330109COM20,000$680,000thousands by filing date
BIOLASE INC090911108COMMON STOCK300,000$660,000thousands by filing date
DYAX CORP26746E103COM65,000$624,000thousands by filing date
VENTRUS BIOSCIENCES INC922822101COM200,000$262,000thousands by filing date
WRIGHT MED GROUP INC98235T115RIGHT 03/01/201955,150$82,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK1,000$66,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001164691-14-000181this filing2014-08-14acceptance time not in the bulk data set